Funder
This project was funded in part by the David and Laura Stone Endowment for Advancement in Neonatal Medicine, Division of Neonatology, Medical University of South Carolina.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health
Reference4 articles.
1. Fowlie PW, Davis PG, McGuire W. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev. 2010;2010:CD000174.
2. Raknoo T, Janjindamai W, Sitaruno S, Dissaneevate S, Ratanajamit C. Incidence, risk and risk factors for acute kidney injury associated with the use of intravenous indomethacin in neonatal patent ductus arteriosus: A 16-year retrospective cohort study. Pharm Pract (Granada). 2021;19:2409.
3. Group. KDIGOKAKIW. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney International Supplement. 2012;2:1–138.
4. Guillet R, Selewski DT, Griffin R, Rastogi S, Askenazi DJ, D’Angio CT. Relationship of patent ductus arteriosus management with neonatal AKI. J Perinatol. 2021;41:1441–7.